~~<i id='F90AE068CA'><strike id='F90AE068CA'><tt id='F90AE068CA'><pre id='F90AE068CA'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

leisure time

Wikipedia

author：focus 2025-09-02 11:45:51 - browse：7631

Alkermes shareholders voted Thursday to re-elect all of the drugmaker’s current directors, ending an acrimonious proxy fight with hedge fund Sarissa Capital Management, which had sought to seat three directors on the board.

At the company’s annual meeting, shareholders voted in favor of Alkermes’ proposal to retain all seven of the director nominees to the 11-person board.

The outcome is a setback for Sarissa, which owns 8.5% of Alkermes and is run by activist investor Alex Denner. Sarissa has accused Alkermes executives of mismanaging the business and destroying shareholder value.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Heart attack and stroke risk calculators need revising
Next article： Sanders wants to replace patents with prizes for drug inventions

focus

leisure time

knowledge

entertainment

Wikipedia

knowledge

AdobeAt14,afternearlythreeyearsofhauntingthelocalurgentcareclinicbecauseofmyintensemenstrualperiods,

WSS

Roche to buy Carmot Therapeutics, developer of obesity drugs

Delta passengers in Vegas fall sick while waiting on flight in triple

Pfizer plans to depart BIO

This biotech could one day make human eggs from scratch. But first, they’re trying to rethink IVF

Patients' immediate access to test results puts radiologists in a bind

A new ‘biological computer' targets cancer while sparing healthy cells

leisure time

Wikipedia

focus

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Radiology is caught between AI's potential and concern for patients

Novavax promises a turnaround & Lilly roils the obesity market

Caribou posts encouraging results on off

Novavax promises a turnaround & Lilly roils the obesity market

Patients' immediate access to test results puts radiologists in a bind

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Despite FDA approval for Lyfgenia, Bluebird faces stiff competition

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

'Golden Bachelor' Gerry Turner reveals what he wants in a partner and more

leisure time

Despite FDA approval for Lyfgenia, Bluebird faces stiff competition

Teach medical students about patients with intellectual disabilities

The stock market has soared this year, but will it last? Experts weigh in

Congenital heart disease patients face new threat of heart failure

US jobless claims fall again as labor market continues to flash strength

There’s a way to spot data fakery. All journals should be using it

knowledge

entertainment

Wikipedia

knowledge